Shrikant Mandlik23 Sep, 2022Health
Global Heparin Market to Ride on the Back of High Prevalence of Cardiovascular Diseases The rising number of surgeries and injuries is projected to be a major cause in the expansion of the global heparin market in the years to come. In addition to that, the rising prevalence of cardiovascular diseases and venous thromboembolism is projected to drive the demand for heparin in near future. Few biopharmaceutical firms are putting money into new drug development and manufacturing. Organizations such as the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC) are working to raise awareness via efforts aimed at reducing thrombosis-related complications in the early stages. The global heparin market is projected to benefit from augmented demand for anticoagulants. In addition to that, high healthcare costs and low patient recognition are two major reasons expected to propel the industry forward in the coming years.
Da88
Crown Medical Figtree
Bates Bruus
Oliver Pang
Powell Alvarado
Tychsen Iqbal
Cardenas Josephsen
Danielsen Michael
Plumbline Answering Service
J88